Sign inJoin waitlistJoin the waitlist

Eileen Shiuan

Hem-Onc, Post Doc · UCLA David Geffen School of Medicine/UCLA Medical Center

Credentials: · · ·

History

UCLA David Geffen School of Medicine/UCLA Medical Center
Present

Hematology and Medical Oncology
UCLA David Geffen School of Medicine/UCLA Medical Center
2024–2027
Internal Medicine
2021–2024
Doctor of Medicine
2017–2021

Research

Oncogenic functions and therapeutic targeting of EphA2 in cancer
Review · Oncogene · 2021 · 140 citations
Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy
Case report · Journal for ImmunoTherapy of Cancer · 2017 · Co-first of 14 authors · 108 citations
The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ
Science Signaling · 2017 · 99 citations

Katy Beckermann
2 papers · 1 as a fellow
AL
Aaron Lim
1 paper
AR
Ariannette Robledo-Gomez
1 paper · 1 as a fellow
Arun Singh
1 paper
Ayaka Sugiura
1 paper
BC
Beiru Chen
1 paper
Benjamin Tillman
1 paper
Benjamin Vincent
1 paper
Brian Rini
1 paper
Catherine Meador
1 paper · 1 as a resident
Christine Lovly
1 paper
CS
Christof Smith
1 paper · 1 as a resident

Grants

Investigating the Role of EphA2 Receptor Tyrosine Kinase in Anti-Tumor Immunity Mediated Through Programmed Cell Death Ligand 2 (PD-L2) in Non-Small Cell Lung Cancer (NSCLC)
National Cancer Institute · F30
Contact PI · $114.7K · Vanderbilt University
2017–2020